THE DEAL, AT A GLANCE

Nanomerics

1/4 reviewed

01Who is involvedBacked by a German strategic investor, with the Silverstein DreamFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

02What happenedNanomerics raised Series A, announced 2026-09-29From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

03Why it mattersIts delivery approach targets medicines that struggle to reach disease sites through normal formulations.Interpretation · Explore ↗

Checked 2026-10-01 · Review due 2026-10-08

MET delivers drugs to the…

Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Nanomerics · Financing Record

Explore source-linked visual explanations for Nanomerics. Unsupported claims are withheld while source review continues.

Record 13087 · Recorded date: 2026-09-29